In this study, we hypothesized that FBXW7 ameliorates the development and progression of NAFLD through abating HMGB1-mediated innate immune signaling to suppress inflammation and consequent insulin resistance. Here, FBXW7 is linked to metabolic dysfunction-associated steatotic liver disease.